Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • CAN LUNG CANCER MAKE YOU TEST POSITIVE FOR COVID-19?

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials put on hold by Serum Institute

COVID-19, not just a pulmonary but also a cardiovascular disease!

CAN LUNG CANCER MAKE YOU TEST POSITIVE FOR COVID-19?
  • BiotechToday
  • FEATURED
  • Latest
  • World

CAN LUNG CANCER MAKE YOU TEST POSITIVE FOR COVID-19?

bioxone September 10, 2020September 10, 2020

–Biswadeep Sen, Amity University Kolkata

Lung Cancer is one of the most malignant tumors, making patients more susceptible to infections than normal individuals. Lung Cancer patients are susceptible to SARS-CoV-2 infection at a significantly higher rate than healthy individuals. Angiotensin-converting enzyme 2, acting as the COVID receptor, and the Transmembrane protease serine 2 acting as the activator of the same are the participants in the Virus’s cell entry.

The COVID envelope houses the Envelope protein (E) which is significantly essential in the assembly and budding of the virus, the Spike protein (S) that comes into play by attaching onto the ACE2 Receptor.

The LCE tests showed that the ACE2 gene was expressed at a higher rate in the LUAD cancer tissue proving it’s the essence of the disease.

The increased expression levels of ACE2 are indicative of the fact that it is indeed responsible for the patient’s susceptibility to the Viral infection.

The gene expression analysis singled out TMPRSS2 as a cancer-suppressing gene in Lung Adenocarcinoma who’s downregulation can decrease the SARS-CoV-2 susceptibility for LUAD patients.

Source: Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection, Kong Q., Xiang Z., Wu Y., et al., Molecular Cancer, 80 (2020).DOI: https://doi.org/10.1186/s12943-020-01209-2

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ACE2 COVID19 Lung Cancer SARS-CoV-2

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • FEATURED
  • India
  • Latest

COVID-19, not just a pulmonary but also a cardiovascular disease!

bioxone September 11, 2020

–Camelia Bhattacharyya, Amity University Kolkata Our body is a natural and the most complicated machine and all of its parts are interrelated. Thus, any change in the environment of one part of the body is likely to cause other changes in most other parts. This theory also holds true when taking into account, the recent […]

Related Post

  • BiotechToday
  • World

Role of the lncRNA complex HCP5 in glioma treatment

bioxone July 7, 2022July 7, 2022

Harini Balasubramanian, Anna University, Chennai The investigation of non-coding regions of the DNA, especially miRNA and long non-coding RNA (lncRNA), and their role in various disease phenotypes, has drawn the attention of scientists in recent years. Gliomas are neoplasias usually found in the brain, a stage IV progression of which leads to glioblastoma (GBM). GBM […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Novel Computational Method to Identify Cyclin Proteins

BioTech Today July 23, 2021July 23, 2021

Sumedha B S, Bangalore University Cyclin Proteins: The cell cycle is the sequence of processes that take place in a cell which ultimately leads to its division into two daughter cells. The mechanism of the cell cycle is regulated by a type of protein called “Cyclins”.  Cyclins bind and activate cyclin-dependent kinases (CDKs). Cyclins were […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Location of working memory:

bioxone October 2, 2020October 2, 2020

Shrestha Dutta, Amity university Kolkata Working memory is imperative for a successful errand – the capacity to hold information in our minds lies at the core of almost everything we do. In a paper in Cell, the scientists present proof that working memory isn’t perfectly bound to one brain area, but requires the simultaneous activity […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy